Difference between revisions of "Template:Latest news"
Shawndouglas (talk | contribs) |
Shawndouglas (talk | contribs) (Updated news.) |
||
| Line 1: | Line 1: | ||
<h2 style="font-size:105%; font-weight:bold; text-align:left; color:#000; padding:0.2em 0.4em; width:50%;"> | <h2 style="font-size:105%; font-weight:bold; text-align:left; color:#000; padding:0.2em 0.4em; width:50%;">May 20, 2020:</h2> | ||
[[File: | [[File:CDC COVID-19 test kit.jpg|left|180px]] '''It pleases me to announce''' the release of Edition 1.0 of the guide ''[[LII:COVID-19 Testing, Reporting, and Information Management in the Laboratory|COVID-19 Testing, Reporting, and Information Management in the Laboratory]]''. Given the rapidly changing state of the [[COVID-19]] pandemic, this guide will receive minor updates every few weeks, or as needed (and thus the decimal editioning). The guide was created to address the evolving status of [[laboratory]] testing, reporting, and information management for the COVID-19 disease and pandemic. Aside from testing, reporting, and informatics topics related to COVID-19 (and other respiratory diseases), the guide also addresses tangential issues such as the slight relaxation of regulatory requirements like [[HIPAA]] and [[CLIA]], as well as the technological advantages and challenges associated with digital [[contact tracing]]. The guide has a strong leaning towards the U.S. demographic, but several aspects of the guide branch out beyond the U.S. I hope you find it useful. | ||
[[User:Shawndouglas|Shawn Douglas]] ([[User talk:Shawndouglas|talk]]) 17 | [[User:Shawndouglas|Shawn Douglas]] ([[User talk:Shawndouglas|talk]]) 18:17, 20 May 2020 (UTC) | ||
<br /> | <br /> | ||
<h2 style="font-size:105%; font-weight:bold; text-align:left; color:#000; padding:0.2em 0.4em; width:50%;"> | <h2 style="font-size:105%; font-weight:bold; text-align:left; color:#000; padding:0.2em 0.4em; width:50%;">March 13, 2020:</h2> | ||
[[File: | [[File:My 420 Tours guide.jpg|left|160px]] '''I'm pleased to announce''' that the third edition of ''[[LII:Past, Present, and Future of Cannabis Laboratory Testing and Regulation in the United States|Past, Present, and Future of Cannabis Laboratory Testing and Regulation in the United States]]'' is now complete. Started in 2017, the guide sought to provide a balanced look at the industry surrounding the ''Cannabis'' plant, particularly in the United States, with a strong focus on laboratory testing. As more U.S. states (and other countries) have legalized the plant's use, the cannabis industry continues to rapidly evolve in ways expected and unexpected. This third edition builds on previous material, adding more historical perspective on changing regulations, standards, and social impacts. It also adds timely topics such as how the insurance market is catering to cannabis companies, and it highlights new efforts to standardize not only laboratory testing but also accreditation of testing labs. One other major move: we've moved primary hosting to the [[cannaqawiki:Main Page|CannaQA wiki]], a wiki similar in vein to this one but with a strong focus on cannabis science. (So what you're seeing here is a mirror of the content.) Enjoy! | ||
[[User:Shawndouglas|Shawn Douglas]] ([[User talk:Shawndouglas|talk]]) 17: | [[User:Shawndouglas|Shawn Douglas]] ([[User talk:Shawndouglas|talk]]) 17:20, 13 March 2020 (UTC) | ||
<br /> | <br /> | ||
Revision as of 18:17, 20 May 2020
May 20, 2020:
It pleases me to announce the release of Edition 1.0 of the guide COVID-19 Testing, Reporting, and Information Management in the Laboratory. Given the rapidly changing state of the COVID-19 pandemic, this guide will receive minor updates every few weeks, or as needed (and thus the decimal editioning). The guide was created to address the evolving status of laboratory testing, reporting, and information management for the COVID-19 disease and pandemic. Aside from testing, reporting, and informatics topics related to COVID-19 (and other respiratory diseases), the guide also addresses tangential issues such as the slight relaxation of regulatory requirements like HIPAA and CLIA, as well as the technological advantages and challenges associated with digital contact tracing. The guide has a strong leaning towards the U.S. demographic, but several aspects of the guide branch out beyond the U.S. I hope you find it useful.
Shawn Douglas (talk) 18:17, 20 May 2020 (UTC)
March 13, 2020:
I'm pleased to announce that the third edition of Past, Present, and Future of Cannabis Laboratory Testing and Regulation in the United States is now complete. Started in 2017, the guide sought to provide a balanced look at the industry surrounding the Cannabis plant, particularly in the United States, with a strong focus on laboratory testing. As more U.S. states (and other countries) have legalized the plant's use, the cannabis industry continues to rapidly evolve in ways expected and unexpected. This third edition builds on previous material, adding more historical perspective on changing regulations, standards, and social impacts. It also adds timely topics such as how the insurance market is catering to cannabis companies, and it highlights new efforts to standardize not only laboratory testing but also accreditation of testing labs. One other major move: we've moved primary hosting to the CannaQA wiki, a wiki similar in vein to this one but with a strong focus on cannabis science. (So what you're seeing here is a mirror of the content.) Enjoy!
Shawn Douglas (talk) 17:20, 13 March 2020 (UTC)
